Type1diabetes: Clinical Trials

6 trials for Type1diabetes, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown, 1 active not recruiting, 1 completed, 1 recruiting. 6 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 46Unknown 2, Active not recruiting 1, Completed 1, Recruiting 1, Withdrawn 1

Follow Type1diabetes: new trials by email Literature Review of Type1diabetes trials Research Report on Type1diabetes

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Tirzepatide Use in People With Obesity and Type 1 Diabetes
Tirzepatide, Placebo - Type1diabetes, Obesity
Phase 4RecruitingDasman Diabetes Institute602025-07-312026-04-20
Diabetes in African Youth
Libre 2, Device for SMBG and Libre Pro - type1diabetes
Phase 4Active not recruitingUniversity of Minnesota1882022-08-152026-11-05
Efficacy and Safety of Recombinant Human Insulin Patch ZJSRM2021
Recombinant Human Insulin Patch ZJSRM2021, Placebo - type1diabetes, Type2 Diabetes
Phase 4UnknownZhejiang Provincial People's Hospital162021-12-012021-11-19
Empagliflozin in Adolescent Diabetes
Empagliflozin - type1diabetes
Phase 4WithdrawnOhio State University2021-07-012023-03-23
Metformin Use to Improve Pregnancy Outcome in Women With Type 1 Diabetes.
metforminhydrochloride, Placebo Oral Tablet - Diabetic Pregnancy, Insulin Resistance
Phase 4CompletedTampere University Hospital1012019-08-052023-06-07
Intermediate and Long Acting Insulin Young Children Type 1 Diabetes.
Degludec, Glargine, NPH insulin - Type 1 Diabetes Mellitus With Hypoglycemia, type1diabetes
Phase 4UnknownAin Shams University602019-02-212021-02-16

Narrower conditions

Diabetes Mellitus, Type 1 (3)  ·  Diabetes Mellitus, Type 2 (1)  ·  Diabetes, Gestational (1)  ·  Inflammation (1)  ·  Insulin Resistance (1)  ·  Obesity (1)  ·  Weight Loss (1)

Broader conditions

Nutritional and Metabolic Diseases (5)  ·  Diabetes Mellitus (4)  ·  Endocrine System Diseases (4)  ·  Glucose Metabolism Disorders (4)  ·  Metabolic Diseases (4)  ·  Autoimmune Diseases (3)  ·  Immune System Diseases (3)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Body Weight (1)  ·  Body Weight Changes (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Hyperinsulinism (1)  ·  Nutrition Disorders (1)  ·  Overnutrition (1)  ·  Overweight (1)

Interventions

Insulin Glargine (1)  ·  Insulin, Isophane (1)  ·  Metformin (1)  ·  Saline Solution (1)  ·  Tirzepatide (1)  ·  empagliflozin (1)  ·  insulin degludec (1)

Sponsors

Ain Shams University (1)  ·  Dasman Diabetes Institute (1)  ·  Ohio State University (1)  ·  Tampere University Hospital (1)  ·  University of Minnesota (1)  ·  Zhejiang Provincial People's Hospital (1)

Countries

United States (2)  ·  China (1)  ·  Egypt (1)  ·  Finland (1)  ·  Kuwait (1)

Top investigators

Antoinette Moran (1)  ·  Ebaa Al Ozairi, MD (1)  ·  Kati Tihtonen, PhD (1)  ·  Safinaz El Habashy (1)  ·  Xiaohong X Wu (1)

Results publications

PMID 40916351, PMID 42097660

NIH funding

2016 (1)